Spyre Therapeutics SYRE
NASDAQ SYRE
$89.93 +0.90 (+1.01%)
At close: Oct 1, 2026 · 4:00 PM EDT

Spyre Therapeutics (SYRE) Total Non-Current Liabilities (2015 - 2026)

Updated

Spyre Therapeutics' Total Non-Current Liabilities came in at $33.24 million for Q2 2026, down 60.0% from $83.06 million a year earlier and down 8.2% from the prior quarter.

Analysis

Spyre Therapeutics (SYRE) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

At the end of FY2025, Spyre Therapeutics' Total Non-Current Liabilities was $35.87 million, up 23.8% from FY2024.

  • Total Non-Current Liabilities carries a five-year compound annual growth rate of 10.7% (FY2020 to FY2025).
  • Going back by year, Total Non-Current Liabilities was $28.98 million in FY2024 (-75.1%), $116.53 million in FY2023 (+459.2%), $20.84 million in FY2022 (-19.8%) and $25.97 million in FY2021 (+20.4%).
  • The Q2 2026 figure represents the lowest quarterly Total Non-Current Liabilities since Q4 2024.
  • Year-over-year, Total Non-Current Liabilities increased in two of the last eight quarters, with an average decline of 8.4%.
  • The fastest year-over-year change in Total Non-Current Liabilities over five years came in Q4 2023 (growth of 459.2%), and the weakest in Q3 2024 (a decline of 86.7%).
  • Business Quant data shows SYRE's Total Non-Current Liabilities at $36.19 million (Q1 2026), $35.87 million (Q4 2025) and $46.27 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 105.99 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 106.45 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -967.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 36.04 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 5.92 Bn
10 Spyre Therapeutics 7.84 Bn 7.84 Bn - 33.24 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 33.24 Mn
Mar 31, 2026 36.19 Mn
Dec 31, 2025 35.87 Mn
Sep 30, 2025 46.27 Mn
Jun 30, 2025 83.06 Mn
Mar 31, 2025 70.68 Mn
Dec 31, 2024 28.98 Mn
Sep 30, 2024 57.54 Mn
Jun 30, 2024 22.12 Mn
Mar 31, 2024 296.22 Mn
Dec 31, 2023 116.53 Mn
Sep 30, 2023 431.98 Mn
Dec 31, 2022 20.84 Mn
Sep 30, 2022 24.01 Mn
Jun 30, 2022 22.55 Mn
Mar 31, 2022 21.51 Mn
Dec 31, 2021 25.97 Mn
Sep 30, 2021 26.79 Mn
Jun 30, 2021 27.76 Mn
Mar 31, 2021 39.65 Mn
API Access

Spyre Therapeutics Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SYRE&period=max&api_key=YOUR_API_KEY